Heparin-binding growth factor(s) derived from head and neck squamous cell carcinomas induce endothelial cell proliferation
- 1 October 1997
- journal article
- research article
- Published by Wiley in Head & Neck
- Vol. 19 (7) , 576-582
- https://doi.org/10.1002/(sici)1097-0347(199710)19:7<576::aid-hed3>3.0.co;2-4
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Vascular Permeability Factor (Vascular Endothelial Growth Factor) Expression and Angiogenesis in Cervical NeoplasiaJNCI Journal of the National Cancer Institute, 1995
- Prognostic significance of prostaglandin E2 production in fresh tissues of head and neck cancer patientsHead & Neck, 1995
- Regulations of Vasculatropin/Vascular Endothelial Growth Factor BioavailabilityHormone Research, 1994
- Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivoNature, 1993
- Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels.The Journal of Experimental Medicine, 1991
- What Is the Evidence That Tumors Are Angiogenesis Dependent?JNCI Journal of the National Cancer Institute, 1990
- Vascular Endothelial Growth Factor Is a Secreted Angiogenic MitogenScience, 1989
- A New Method for purifying Heparin-binding Growth FactorsAnnals of the New York Academy of Sciences, 1989
- Heparin Affinity: Purification of a Tumor-Derived Capillary Endothelial Cell Growth FactorScience, 1984
- ISOLATION OF A TUMOR FACTOR RESPONSIBLE FOR ANGIOGENESISThe Journal of Experimental Medicine, 1971